TLSA Projected Dividend Yield

Ord/Tiziana Life Sciences Ltd ( NASDAQ : TLSA )

Tiziana Life Sciences is a biotechnology company that is focused on the discovery and development of molecules to treat unmet medical needs in oncology and immunology. Co.'s main product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody (mAb) in clinical development. MAbs represent a single pure antibody produced by single clones and are a class of human therapeutics for treating cancers and autoimmune diseases. Co.'s main product candidate in oncology is Milciclib (TZLS-201), which is an orally bioavailable, small molecule spectrum inhibitor of cyclin-dependent kinases, and Src family kinases.

20 YEAR PERFORMANCE RESULTS

TLSA Dividend History Detail
TLSA Dividend News
TLSA Competitors News
# of Shares: 0 Closing Price: 0.94 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor